Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for uncomplicated malaria in Ugandan children
ISRCTN15793046Phase 4Completed
- Sponsor
- Ministry of Health of Uganda
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in malaria comparing Artemether-lumefantrine with Dihydroartemisinin-piperaquine (2 arms). Primary endpoint: Risk of parasitological treatment failure. Started Sep 2015; status: completed.
02
Drugs
artemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN15793046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15793046.